Impact of dose escalation on colostomy-free survival and treatment outcome in squamous cell anal carcinoma

被引:0
作者
Sebastian Untiedt
Daniel Rolf
Sergiu Scobioala
Heidi Wolters
Khaled Elsayad
Michael Oertel
Christopher Kittel
Andreas Pascher
Emile Rijcken
Hansjörg Ullerich
Bernhard Glasbrenner
Hans Theodor Eich
机构
[1] University Hospital Muenster,Department of Radiation Oncology
[2] University Hospital Muenster,Department for General, Visceral and Transplant Surgery
[3] University Hospital Muenster,Department of Medicine B, Gastroenterology
[4] St. Franziskus-Hospital Muenster,Department of Medicine B, Gastroenterology
来源
Strahlentherapie und Onkologie | 2023年 / 199卷
关键词
Anal cancer; Radiotherapy; Radiation boost; Intensity-modulated radiotherapy; Toxicities;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:749 / 760
页数:11
相关论文
共 643 条
[1]  
Islami F(2017)International trends in anal cancer incidence rates Int J Epidemiol 46 924-938
[2]  
Ferlay J(1974)Combined therapy for cancer of the anal canal: a preliminary report Dis Colon Rectum 17 354-356
[3]  
Lortet-Tieulent J(1981)Combined therapy for cancer of the anal canal Dis Colon Rectum 24 73-75
[4]  
Bray F(1983)Combined preoperative radiation and chemotherapy for squamous cell carcinoma of the anal canal Cancer 51 1826-1829
[5]  
Jemal A(2021)Anal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up Ann Oncol 32 1087-1100
[6]  
Nigro ND(1996)Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin Lancet 348 1049-1054
[7]  
Vaitkevicius VK(1997)Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups J Clin Oncol 15 2040-2049
[8]  
Considine BJ(1996)Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study J Clin Oncol 14 2527-2539
[9]  
Nigro ND(2022)Evaluation of prognostic factors after primary chemoradiotherapy of anal cancer: A multicenter study of the German Cancer Consortium-Radiation Oncology Group (DKTK-ROG) Radiother Oncol 167 233-238
[10]  
Vaitkevicius VK(2013)RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal Int J Radiat Oncol Biol Phys 86 27-33